COVID-19 in children treated with immunosuppressive medication for kidney diseases

202061 citationsJournal Articlehybrid Open Access

Authors

Matko Marlais · Great Ormond Street Hospital for Children NHS Foundation Trust

Tanja Wlodkowski · Heidelberg University

Samhar Al‐Akash · Driscoll Children's Hospital

Petr V. Ananin · Scientific Center of Children's Health

Varun Kumar Bandi · Institute of Medical Sciences

Véronique Baudouin · Assistance Publique – Hôpitaux de Paris

Olivia Boyer

Abstract

This global study shows most children with a kidney disease taking immunosuppressive medication have mild disease with SARS-CoV-2 infection. We therefore suggest that children on immunosuppressive therapy should not be more strictly isolated than children who are not on immunosuppressive therapy.

Topics & Keywords

COVID-19 Clinical Research Studies Kawasaki Disease and Coronary Complications COVID-19 Impact on Reproduction

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Archives of Disease in Childhood

Volume 106, Issue 8, pp. 798-801

DOI: 10.1136/archdischild-2020-320616

Field-Weighted Citation Impact: 1.38